Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease.
about
Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body diseaseAmyloid-Beta Induced Changes in Vesicular Transport of BDNF in Hippocampal NeuronsReactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic PlasticitySynaptopathies: synaptic dysfunction in neurological disorders - A review from students to studentsGlutamate and GABA imbalance following traumatic brain injuryIntrahippocampal administration of a domain antibody that binds aggregated amyloid-β reverses cognitive deficits produced by diet-induced obesity.Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysisd-serine levels in Alzheimer's disease: implications for novel biomarker developmentWhy are neurotransmitters neurotoxic? An evolutionary perspectiveFragile X mental retardation protein: from autism to neurodegenerative disease.The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivationThe Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammationThe nuclear retention of transcription factor FOXO3a correlates with a DNA damage response and increased glutamine synthetase expression by astrocytes suggesting a neuroprotective role in the ageing brain.Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease.Astaxanthin Protects Primary Hippocampal Neurons against Noxious Effects of Aβ-Oligomers.Alzheimer's disease and the microbiome.Phenotypic Alterations in Hippocampal NPY- and PV-Expressing Interneurons in a Presymptomatic Transgenic Mouse Model of Alzheimer's Disease.Combining two repurposed drugs as a promising approach for Alzheimer's disease therapyEnvironmental factors in the development and progression of late-onset Alzheimer's disease.Involvement of 'stress-response' kinase pathways in Alzheimer's disease progression.The gastrointestinal tract microbiome and potential link to Alzheimer's disease.Generation of the Cdk5 activator p25 is a memory mechanism that is affected in early Alzheimer's disease.The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease.Autophagy-ERK1/2-Involved Disinhibition of Hippocampal Neurons Contributes to the Pre-Synaptic Toxicity Induced by Aβ42 Exposure.Genistein Inhibits Aβ25-35-Induced Synaptic Toxicity and Regulates CaMKII/CREB Pathway in SH-SY5Y Cells.Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature.Ionotropic glutamate receptors: Which ones, when, and where in the mammalian neocortex.Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease.Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses.Amyloid β-peptide oligomers, ryanodine receptor-mediated Ca(2+) release, and Wnt-5a/Ca(2+) signaling: opposing roles in neuronal mitochondrial dynamics?Ryanodine receptor-mediated Ca(2+) release underlies iron-induced mitochondrial fission and stimulates mitochondrial Ca(2+) uptake in primary hippocampal neurons.The transcription factor XBP1 in memory and cognition: Implications in Alzheimer disease.Aβ42 oligomers modulate β-secretase through an XBP-1s-dependent pathway involving HRD1.Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathiesDihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer's disease.A functional SNP catalog of overlapping miRNA-binding sites in genes implicated in prion disease and other neurodegenerative disorders.Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects.
P2860
Q26853610-DBEF278F-0661-4220-8368-8F52C47F8ED9Q27313482-4A813602-03A6-40C3-8B1D-E7EBAEEC9FDBQ28070007-6744D77A-3702-4E07-B09F-36442CAFEB43Q28077671-6409AFE9-4EAF-4077-B936-763B7F6BA941Q28081232-4D6BD9D3-4FD7-4B36-8693-FAE2777A7368Q30277159-F396D4C3-1CD4-486B-9331-4B2B365DD256Q30678146-A559E9D5-99D1-4A8C-A92E-D3C493E43E76Q34435017-4685E9B8-CCB1-49F3-9EB2-384AA9843BAEQ34475073-DD43FB81-5647-4C3A-A84B-0DE216C85238Q34885948-09242821-0807-43B7-A7EB-EE0B26A9CF34Q35077291-3E7612E9-0E9C-4D76-9782-57A0CA02437CQ35484349-18E57E3A-DCD4-4A59-8928-F39BAE4AEFCBQ35800000-02B88E78-FE0F-4E98-AB52-98B4AD1FEAE3Q36238937-274D601D-5519-4C0E-BB53-7D76D9F64DDCQ36360986-2CE65762-AC0B-410E-87AE-389157FA623CQ36483870-526A6B2A-6064-4901-A649-20B84D36E572Q36686173-59D12BCD-CC8A-4B5F-87C5-81E35AD1CCFEQ37178073-D226FC2C-6F34-4F12-9A35-9E047123D715Q37592706-B18E92C0-9220-427D-B743-4A11A4EABD64Q37736317-47667376-3FA1-433C-94FB-0D38A7C8A9E8Q38199061-B9A2DB2B-13DD-43BB-B89A-08538F122D1AQ38202756-36CBEBB9-1348-485A-BE26-7309FC753296Q38207585-88DAA0E4-261B-4FD0-847B-AFF98701415DQ38211426-5890746A-D3BA-444C-8D7D-54E55A3D4EE7Q38400601-5D9CB7E0-A428-4751-A0B4-315D2074CC5BQ38683916-3692192C-0699-45B6-96A9-5B1BAE766286Q38812298-89A24CD8-6532-4F64-90BB-E950369997CFQ38816381-9534B613-55C0-4A35-AA55-115C79B63600Q38936972-5E6383F8-79C5-465D-AFF4-7F1A67134030Q38955990-889C22E4-CF52-43ED-A263-1DF803339E9EQ38962792-F558934B-6A21-48DC-8A0D-D49A92F3A77EQ39043782-5A29BAEF-8116-4AFF-9BB8-DE2BF27D3094Q41770757-D87B6B7A-06FB-4DD0-A170-D187837B6C22Q41776723-0EE64BC0-8AD1-4250-8699-0BF3BF09D15EQ41828232-252D4AAF-CDA3-4E3A-9935-CDD8C8CF96DCQ42053390-5BCFC819-AB11-41CD-AC72-7C6A86E132DFQ42371467-74F76B63-6B5E-4A55-AF9F-78C57C0C0ADBQ43427045-0BF55B08-951D-4B40-9517-F6486C6CDEA4Q47990584-087E76CF-B147-4B97-BB75-BB70D7B5CB0BQ48237879-95FF2F03-57C4-43F2-88B7-032A1DDA278D
P2860
Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Deregulation of excitatory neu ...... ailure in Alzheimer's disease.
@en
type
label
Deregulation of excitatory neu ...... ailure in Alzheimer's disease.
@en
prefLabel
Deregulation of excitatory neu ...... ailure in Alzheimer's disease.
@en
P2093
P2860
P356
P1476
Deregulation of excitatory neu ...... ailure in Alzheimer's disease.
@en
P2093
Andrea C Paula-Lima
Jordano Brito-Moreira
Sergio T Ferreira
P2860
P304
P356
10.1111/JNC.12304
P407
P577
2013-05-28T00:00:00Z